Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1

3(37.5%)

N/A

3(37.5%)

Phase 2

2(25.0%)

8Total

Phase 1(3)

N/A(3)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07416539Phase 1Recruiting

Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19

Role: collaborator

NCT06659562Phase 1Completed

Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients With Parkinson's Disease

Role: collaborator

NCT03570450Phase 1Recruiting

Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1

Role: collaborator

NCT02849613Phase 2Withdrawn

Regenerative Stem Cell Therapy for Stroke in Europe

Role: collaborator

NCT04229082Completed

Next Generation Probiotics (NGPs) for Metabolic Health

Role: collaborator

NCT03729219Phase 2Completed

Prevention of Diarrheal Disease Due to Infection With Enterotoxigenic E. Coli (ETEC)

Role: collaborator

NCT03352856Not ApplicableSuspended

Food Challenge With Barley Starch as Active Comparator

Role: collaborator

NCT03346486Not ApplicableCompleted

Dietary Intervention With Brain-friendly Diet

Role: collaborator

NCT03284918Not ApplicableCompleted

Lipid Lowering Effect of a Cereal Based Snack Bar With Added Plant Stanol Ester

Role: collaborator

All 9 trials loaded